As of 2025-09-17, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (57.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -69050.2%.
The range of the Relative Valuation is (48.62) - (59.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 20.5x | 18.0x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (48.62) - (59.33) | (57.23) |
| Upside | -58677.1% - -71578.0% | -69050.2% |
| Date | P/E |